Aim. To study secondary prevention of cardiovascular diseases among patients of different age groups with a history of myocardial infarction by the example of outpatient cardiology institution. Material and methods. Retrospective pharmacoepidemiological study was conducted by analyzing the medical records of 825 patients with a history of myocardial infarction, who visited the outpatient cardiology institution for the first time in 2011. Patients were divided into two groups according to their age: younger than 60 years (n=308), and 60 years and older (n=517). Results. The population of elderly patients was more severe: significantly more often patients had disability and co-morbidities. The prevalence of the main modifiable risk factors co...
AIMS: Persistent use of guideline-recommended drugs after acute myocardial infarction (AMI) is frequ...
Background: Deficiencies in implementation of secondary prevention of coronary heart disease (CHD) h...
Despite all the achievements and progress of contemporary science and practice, the cardiovascular d...
Objective: To examine the extent of uptake of medication for secondary prevention of coronary heart ...
Secondary preventive drug treatment in patients aged > or =60 years with a history of myocardial inf...
Aim. To assess the real clinical practice implementation of the recommendations on secondary cardiov...
Background: The highest priority in preventive cardiology was given to patients with estab-lished co...
Background: In patients with ischemic heart disease (IHD), secondary preventive drug therapy improve...
Background: Aging is a major risk factor for atherosclerotic cardiovascular diseases (CVD) and death...
Aim. To assess 5 years trend in level of doctor's adherence to actual guidelines on secondary preven...
© 2017, International Society of Behavioral Medicine. Purpose: Evidence is limited on implementation...
In this thesis we observe that prescription rates of lipid-lowering drugs and antithrombotic medicat...
The two-stage retrospective review of 1375 medical records of ambulatory patients with myocardial in...
Background: Secondary prevention plays an important role after acute coronary event due to high risk...
WOS: 000461568600003PubMed ID: 28980279Background: Secondary prevention plays an important role afte...
AIMS: Persistent use of guideline-recommended drugs after acute myocardial infarction (AMI) is frequ...
Background: Deficiencies in implementation of secondary prevention of coronary heart disease (CHD) h...
Despite all the achievements and progress of contemporary science and practice, the cardiovascular d...
Objective: To examine the extent of uptake of medication for secondary prevention of coronary heart ...
Secondary preventive drug treatment in patients aged > or =60 years with a history of myocardial inf...
Aim. To assess the real clinical practice implementation of the recommendations on secondary cardiov...
Background: The highest priority in preventive cardiology was given to patients with estab-lished co...
Background: In patients with ischemic heart disease (IHD), secondary preventive drug therapy improve...
Background: Aging is a major risk factor for atherosclerotic cardiovascular diseases (CVD) and death...
Aim. To assess 5 years trend in level of doctor's adherence to actual guidelines on secondary preven...
© 2017, International Society of Behavioral Medicine. Purpose: Evidence is limited on implementation...
In this thesis we observe that prescription rates of lipid-lowering drugs and antithrombotic medicat...
The two-stage retrospective review of 1375 medical records of ambulatory patients with myocardial in...
Background: Secondary prevention plays an important role after acute coronary event due to high risk...
WOS: 000461568600003PubMed ID: 28980279Background: Secondary prevention plays an important role afte...
AIMS: Persistent use of guideline-recommended drugs after acute myocardial infarction (AMI) is frequ...
Background: Deficiencies in implementation of secondary prevention of coronary heart disease (CHD) h...
Despite all the achievements and progress of contemporary science and practice, the cardiovascular d...